You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AKT

Showing 1 - 25 of 1,039
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Middletown, New Jersey
  • +2 more
Jul 5, 2022

Living Donor Kidney Transplantation Trial in Edmonton (MuST AKT)

Not yet recruiting
  • Living Donor Kidney Transplantation
  • MuST AKT
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
Jul 12, 2022

Kidney Diseases, Social Determinants of Health Trial (Kidney Transplant Fast Track (KTFT), Peer Navigation (PN))

Not yet recruiting
  • Kidney Diseases
  • Social Determinants of Health
  • Kidney Transplant Fast Track (KTFT)
  • Peer Navigation (PN)
  • (no location specified)
Oct 25, 2022

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

Active, not recruiting
Has Results
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Living Donor Kidney Transplantation Trial in Edmonton (MuST AKT)

Recruiting
  • Living Donor Kidney Transplantation
  • MuST AKT
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
Jan 10, 2022

CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,

Terminated
Has Results
  • Central Nervous System Lymphoma
  • +6 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 30, 2022

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
Has Results
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Kidney Diseases Trial in Albuquerque (Kidney Transplant Fast Track (KTFT), Peer Navigation (PN))

Recruiting
  • Kidney Diseases
  • Kidney Transplant Fast Track (KTFT)
  • Peer Navigation (PN)
  • Albuquerque, New Mexico
    University of New Mexico
Dec 8, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Calgary, Alberta, Canada
  • +4 more
Feb 10, 2022

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • Laboratory Biomarker Analysis
  • Boston, Massachusetts
  • +6 more
Jan 13, 2022

Breast Cancer Trial in Boston (Ipatasertib, Fulvestrant, Aromatase Inhibitor)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 25, 2021

Colorectal Adenomatous Polyp, Colorectal Carcinoma, Familial Adenomatous Polyposis Trial in United States (procedure, drug,

Not yet recruiting
  • Colorectal Adenomatous Polyp
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
  • +4 more
Jan 3, 2023

Advanced Solid Tumors Trial (WGI-0301)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 11, 2022

Seborrheic Keratosis Trial in Santa Tecla (SM-020)

Recruiting
  • Seborrheic Keratosis
  • Santa Tecla, La Libertad, El Salvador
    Zepeda Dermatologia
Aug 20, 2022

Triple Negative Breast Cancer Trial in Madison (Akt/ERK Inhibitor ONC201, Methionine-Restricted Diet)

Terminated
Has Results
  • Triple Negative Breast Cancer
  • Akt/ERK Inhibitor ONC201
  • Methionine-Restricted Diet
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 11, 2022

Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

Recruiting
  • Breast Neoplasm
  • +4 more
  • PIK3CA inhibitor
  • +12 more
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jan 2, 2023

Solid Tumor, Adult Trial in Seoul (TAS-117)

Completed
  • Solid Tumor, Adult
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 21, 2021

Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

Recruiting
  • Esophagus Adenocarcinoma
  • +2 more
  • Dallas, Texas
    Dallas VA Medical Center
Nov 2, 2021